Aster Capital Management (Difc) LTD Standard Biotools Inc. Transaction History
Aster Capital Management (Difc) LTD
- $462 Billion
- Q3 2024
A detailed history of Aster Capital Management (Difc) LTD transactions in Standard Biotools Inc. stock. As of the latest transaction made, Aster Capital Management (Difc) LTD holds 59 shares of LAB stock, worth $107. This represents 0.0% of its overall portfolio holdings.
Number of Shares
59Holding current value
$107% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding LAB
# of Institutions
142Shares Held
279MCall Options Held
27.2KPut Options Held
34.1K-
Casdin Capital, LLC New York, NY71.3MShares$130 Million10.68% of portfolio
-
Viking Global Investors LP58.7MShares$107 Million0.44% of portfolio
-
Black Rock Inc. New York, NY21.8MShares$39.6 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA17.3MShares$31.5 Million0.0% of portfolio
-
Morgan Stanley New York, NY15.2MShares$27.7 Million0.0% of portfolio
About STANDARD BIOTOOLS INC.
- Ticker LAB
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 78,654,800
- Market Cap $143M
- Description
- Standard BioTools Inc. creates, manufactures, and markets instruments, consumables, reagents, and software for researchers and clinical laboratories worldwide. It offers analytical systems, such as Helios, a CyTOF system, as well as Hyperion imaging systems, Hyperion tissue imagers, and flow conductors; and assays and reagents, including Maxpar ...